查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402582

早产和胎膜早破测试市场：按产品类型、按测试类型、按最终用户、按地区

Preterm Birth and PROM Testing Market, By Product Type, By Test Type, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

早产和胎膜早破检测的市场规模预计将从 2023 年的 17 亿美元增加到 2030 年的 26 亿美元，预测期内复合年增长率为 6.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 17亿美元
实际资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.30% 2030年市场规模预测 26亿美元
图 1. 2023 年按地区分類的早产和胎膜早破测试的全球市场占有率(%)
早产和胎膜早破测试市场-IMG1

早产，又称早产，是一个重大的全球健康问题。早产是指妊娠37週前出生。根据世界卫生组织 (WHO) 统计，每年约有 1500 万婴儿早产，约占全球新生儿的十分之一。早产可导致多种健康併发症，是新生儿死亡和发病的主要原因之一。

PROM测试代表产前胎膜破裂，是用于评估早产风险的重要诊断工具。有助于在分娩开始前及早发现胎膜破裂。透过检测羊水的存在，胎膜早破测试可以帮助医疗保健专业人员在管理和照顾有早产风险的孕妇方面做出明智的决定。

市场动态：

早产和胎膜早破检测市场主要是由全球早产发生率上升所推动的。产妇年龄、多胎妊娠、产前护理不足、感染疾病和社会经济因素等因素导致早产增加。 PROM 检测在识别早产风险方面发挥着重要作用，使医疗保健专业人员能够及时采取干预措施并改善新生儿结果。

然而，也存在阻碍市场成长的因素。其中包括胎膜早破检测套组价格高昂、发展中地区医疗机构的使用机会有限以及孕妇和医护人员对早产和胎膜早破检测的认识较低。

同时，由于 PROM 测试的技术进步、对即时检测的日益关注以及对个人化医疗的需求不断增长，市场上存在着巨大的商机。市场参与者正在投资研发工作，以开发创新的 PROM检测套组，以提高准确性、易用性和成本效益。

总体而言，由于早产意识的提高、胎膜早破检测方法的进步以及早期检测和早期疗育以改善新生儿结局的需求，早产和胎膜早破检测市场正在经历显着增长。市场相关人员正在采取策略来扩大产品系列、与主要相关人员合作并探索未开发的市场潜力。

本研究的主要特点

  • 本报告对全球早产和胎膜早破检测市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
  • 它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球早产和胎膜早破测试市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球早产和胎膜早破测试市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球早产和胎膜早破测试市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品类型启动/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第 4 章 早产和胎膜早破测试市场 –冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章 2018-2030 年早产及胎膜早破测试市场（依产品类型）

  • 套件和试剂
  • 用具
  • 消耗品

第六章 2018-2030 年早产及胎膜早破测试市场（依测试类型）

  • 骨盆腔检查
  • 超音波
  • 子宫监测
  • 生物标记测试
  • 其他的

第 7 章 2018-2030 年早产和胎膜早破测试市场（按最终用户划分）

  • 医院
  • 诊断实验室
  • 门诊
  • 研究中心
  • 其他的

第 8 章 2018-2030 年早产及胎膜早破检验市场（按地区）

  • 北美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争形势

  • Abbott Laboratories
  • Biosynex
  • Qiagen NV
  • Clinical Innovations, LLC
  • Sera Prognostics
  • Hologic, Inc.
  • IQ Products
  • NX Prenatal, Inc.
  • Promega Corporation
  • Insight Pharmaceuticals LLC
  • Creative Diagnostics

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6403

The preterm birth and PROM testing market size is expected to reach US$ 2.6 Bn by 2030, from US$ 1.7 Bn in 2023, at a CAGR of 6.3% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.7 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.30% 2030 Value Projection: US$ 2.6 Bn
Figure 1. Global Preterm Birth and PROM Testing Market Share (%), by Region, 2023
Preterm Birth and PROM Testing Market - IMG1

Preterm birth, also known as premature birth, is a significant global health concern. It refers to the birth of a baby before 37 completed weeks of gestation. According to the World Health Organization (WHO), around 15 million babies are born prematurely each year, accounting for approximately one in 10 births worldwide. Preterm birth can lead to various health complications and is one of the leading causes of neonatal mortality and morbidity.

PROM testing, which stands for prelabor rupture of membranes, is an important diagnostic tool used to assess the risk of preterm birth. It helps in the early detection of membrane rupture before the onset of labor. By detecting the presence of amniotic fluid, PROM testing helps healthcare professionals make informed decisions regarding the management and care of pregnant women at risk of premature birth.

Market Dynamics:

The preterm birth and PROM testing market is primarily driven by the increasing incidence of preterm births worldwide. Factors, such as maternal age, multiple pregnancies, poor prenatal care, infections, and socioeconomic factors, contribute to the rise in preterm births. PROM testing plays a crucial role in identifying the risk of preterm birth, enabling healthcare professionals to provide timely interventions and improve neonatal outcomes.

However, there are certain restraints that can hinder the growth of the market. These include the high cost of PROM testing kits, limited access to healthcare facilities in developing regions, and the lack of awareness about preterm birth and PROM testing among pregnant women and healthcare providers.

On the other hand, there are significant opportunities in the market, driven by technological advancements in PROM testing methods, increasing focus on point-of-care testing, and the growing demand for personalized medicine. Market players are investing in research and development activities to develop innovative PROM testing kits with improved accuracy, ease of use, and cost-effectiveness.

Overall, the preterm birth and PROM testing market is witnessing substantial growth, driven by the increasing awareness about preterm birth, advancements in PROM testing methods, and the need for early detection and intervention to improve neonatal outcomes. Market players are strategizing to expand their product portfolios, collaborate with key stakeholders, and explore the untapped market potential.

Key Features of the Study:

  • This report provides an in-depth analysis of the global preterm birth and PROM testing market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global preterm birth and PROM testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Biosynex, Qiagen N.V., Clinical Innovations, LLC, Sera Prognostics, Hologic, Inc., IQ Products, NX Prenatal, Inc., PROMega Corporation, Insight Pharmaceuticals LLC, and Creative Diagnostics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global preterm birth and PROM testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preterm birth and PROM testing market

Detailed Segmentation:

  • By Product Type
    • Kits and Reagents
    • Instruments
    • Consumables
  • By Test Type
    • Pelvic exam
    • Ultrasound
    • Uterine monitoring
    • Biomarker testing
    • Others
  • By End User
    • Hospitals
    • Diagnostics laboratories
    • Outpatient clinics
    • Research centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Preterm Birth and PROM Testing Market
    • Abbott Laboratories
    • Biosynex
    • Qiagen Sciences LLC
    • Clinical Innovations, LLC
    • Sera Prognostics
    • Hologic, Inc.
    • IQ Products
    • NX Prenatal, Inc.
    • Promega Corporation
    • Medical predictive Technologies Inc.
    • Creative Diagnostics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Preterm Birth And PROM Testing Market, By Product Type
    • Preterm Birth And PROM Testing Market, By Test Type
    • Preterm Birth And PROM Testing Market, By End User
    • Preterm Birth And PROM Testing Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of preterm births
    • High costs of prenatal diagnostic tests
    • Significant untapped potential in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Type Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Preterm Birth and PROM Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Preterm Birth and PROM Testing Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Kits and Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

6. Preterm Birth and PROM Testing Market, By Test Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pelvic exam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Ultrasound
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Uterine monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Biomarker testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Preterm Birth and PROM Testing Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Diagnostics laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Outpatient clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Research centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Preterm Birth and PROM Testing Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Type Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biosynex
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Qiagen N.V.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Clinical Innovations, LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sera Prognostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • IQ Products
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • NX Prenatal, Inc.
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Promega Corporation
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Insight Pharmaceuticals LLC
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Creative Diagnostics
    • Company Highlights
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us